AI MARKET SCANNING

PDS Biotechnology Corporation

📅 Next Catalyst: Nov 12, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +0.24%
MAX GAP RECORD -20.15%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $PDSB
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 13, 2026 Earnings Release 2026-08-13 (BEFORE OPEN)
+0.00%
Mar 30, 2026 Earnings Release 2026-03-30 (BEFORE OPEN)
+11.65%
Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE)
+2.01%
Aug 13, 2025 Earnings Release 2025-08-13 (BEFORE OPEN)
+2.44%
May 14, 2025 Earnings Release 2025-05-14 (BEFORE OPEN)
+3.94%
Mar 27, 2025 Earnings Release 2025-03-27 (BEFORE OPEN)
+2.42%
Nov 14, 2024 Earnings Release 2024-11-14 (BEFORE OPEN)
-20.15%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.6%
Bullish Gaps (7)
Bearish Gaps (3)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $PDSB

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products include PDS0101 and PDS01ADC. The company was founded by Frank K. Bedu-Addo in 2005 and…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗